Grupo de investigación en Terapia Celular e Medicina Rexenerativa (TCMR): Recent submissions
Now showing items 11-15 of 147
-
There is something you must see: breaking down the remission concept in rheumatoid arthritis from a rheumatologist's perspective
(Clinical and Experimental Rheumatology, 2020-01)[Abstract] Objectives: To explore the remission concept in rheumatoid arthritis (RA) and the implications of the existing definitions when applied to clinical practice among rheumatologists with different profiles. Methods: ... -
Formononetin, a beer polyphenol with catabolic effects on chondrocytes
(MDPI, 2023-06-29)[Abstract] Beer consumption has been identified as a risk factor for osteoarthritis (OA), a rheumatic disease characterised by cartilage degradation, joint inflammation, and eventual joint failure. One of the main isoflavonoids ... -
Methylphenidate promotes premature growth plate closure: in vitro evidence
(MDPI, 2023-02-20)[Abstract] It is well known that patients with attention deficit hyperactivity disorder treated with stimulants, such as methylphenidate hydrochloride (MPH), have reduced height and weight. Even though MPH has an anorexigenic ... -
Effect of miR-21 in mesenchymal stem cells-derived extracellular vesicles behavior
(BioMed Central, 2023-12-21)[Abstract] Background: A challenging new branch of research related to aging-associated diseases is the identification of miRNAs capable of modulating the senescence-associated secretory phenotype (SASP) which characterizes ... -
Mesenchymal stem cell therapy in traumatic spinal cord injury: a systematic review
(MDPI, 2023-07-20)[Abstract] Recovery from a traumatic spinal cord injury (TSCI) is challenging due to the limited regenerative capacity of the central nervous system to restore cells, myelin, and neural connections. Cell therapy, particularly ...